1 |
de Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care [J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(4): 561-570.
|
2 |
Lipshultz SE, Adams MJ, Colan SD, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association [J]. Circulation, 2013, 128(17): 1927-1995.
|
3 |
Armenian SH, Xu L, Ky B, et al. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study [J]. J Clin Oncol, 2016, 34(10): 1122-1130.
|
4 |
Yeh ET, Chang HM. Oncocardiology-Past, Present, and Future: A Review [J]. JAMA Cardiol, 2016, 1(9): 1066-1072.
|
5 |
Barac A, Murtagh G, Carver JR, et al. Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level [J]. J Am Coll Cardiol, 2015, 65(25): 2739-2746.
|
6 |
Ewer MS, Vooletich MT, Durand JB, et al. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment [J]. J Clin Oncol, 2005, 23(31): 7820-7826.
|
7 |
Khouri MG, Douglas PS, Mackey JR, et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues [J]. Circulation, 2012, 126(23): 2749-2763.
|
8 |
Narayan V, Ky B. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention [J]. Annu Rev Med, 2018, 69: 97-111.
|
9 |
Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. J Am Soc Echocardiogr, 2014, 27(9): 911-939.
|
10 |
Lancellotti P, Nkomo VT, Badano LP, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography [J]. Eur Heart J Cardiovasc Imaging, 2013, 14(8): 721-740.
|
11 |
Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review [J]. J Am Coll Cardiol, 2014, 63(25 Pt A): 2751-2768.
|
12 |
Chen-Scarabelli C, Hundley WG, Scarabelli TM. Cardio-oncology: an evolving hybrid subspecialty [J]. Future Cardiol, 2018, 14(3): 197-201.
|
13 |
毕小军, 邓又斌, 曾繁静, 等. 二维应变超声心动图评价乳腺癌患者表阿霉素化疗后左心室收缩功能 [J]. 中国医学影像技术, 2009, 25(8): 1415-1418.
|
14 |
陈娜, 郑慧, 周旺, 等. 三维斑点追踪成像及左心室整体心肌应变评价化疗对肺癌患者的心脏毒性 [J]. 安徽医科大学学报, 2016, 51(11): 1638-1642.
|
15 |
王佳玉, 邓又斌. 超声心动图评价恶性肿瘤治疗相关心脏毒性的研究进展 [J]. 中华超声影像学杂志, 2017, 26(8): 733-735.
|
16 |
徐艳萍, 纳丽莎, 贾梅, 等. 常规超声心动图对乳腺癌患者蒽环类药物化疗后心脏毒性的监测 [J]. 宁夏医科大学学报, 2016, 38(4): 456-458.
|
17 |
杨瑛, 智光. 超声心动图在化疗监测中的应用 [J]. 临床荟萃, 2017, 32(4): 365-368.
|
18 |
张楚婕, 程蕾蕾, 宋飞艳, 等. Tei指数联合血清超敏肌钙蛋白T早期诊断蒽环类化疗药物致心脏毒性的价值 [J]. 中华超声影像学杂志, 2017, 26(5): 387-392.
|
19 |
Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments [J]. Nat Rev Cardiol, 2015, 12(9): 547-558.
|
20 |
Hensley ML, Hagerty KL, Kewalramani T, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants [J]. J Clin Oncol, 2009, 27(1): 127-145.
|
21 |
Casper ES, Gaynor JJ, Hajdu SI, et al. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors [J]. Cancer, 1991, 68(6): 1221-1229.
|
22 |
Jones LW, Habel LA, Weltzien E, et al. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer [J]. J Clin Oncol, 2016, 34(23): 2743-2749.
|
23 |
Berkman AM, Lakoski SG. The potential of aerobic exercise training in mitigating cardiovascular side effects of cancer therapy [J]. Future Cardiol, 2015, 11(4): 407-411.
|
24 |
Hampton T. Cardio-Oncology Programs Strive to Balance Cancer Care With Heart Health [J]. Circulation, 2016, 134(4): 353-354.
|
25 |
Barac A. Improving prediction of cardiovascular complications of cancer therapy: what does the future hold? [J]. Future Cardiol, 2015, 11(4): 383-387.
|